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Silver activationNowadays, with the increase of elderly population and related health problems, knee and hip joint prosthesis are
being widely used worldwide. However, failure of these invasive devices occurs in a high percentage thus de-
manding the revision of the chirurgical procedure. Within the reasons of failure, microbial infections, either hos-
pital or subsequently-acquired, contribute in high number to the statistics. Staphylococcus epidermidis
(S. epidermidis) has emerged as one of the major nosocomial pathogens associated with these infections. Silver
has a historic performance inmedicine due to its potent antimicrobial activity, with a broad-spectrum on the ac-
tivity of different types of microorganisms. Consequently, the main goal of this work was to produce Ag–ZrCN
coatings with antimicrobial activity, for the surface modiﬁcation of hip prostheses.
Thin ﬁlms of ZrCN with several silver concentrations were deposited onto stainless steel 316 L, by DC reactive
magnetron sputtering, using two targets, Zr and Zrwith silver pellets (Zr+Ag target), in an atmosphere contain-
ing Ar, C2H2 and N2. The antimicrobial activity of the modiﬁed surfaces was tested against S. epidermidis and the
inﬂuence of an activation step of silver was assessed by testing samples after immersion in a 5% (w/v) NaClO so-
lution for 5 min.
The activation procedure revealed to be essential for the antimicrobial activity, as observed by the presence of an
inhibition halo on the surface with 11 at.% of Ag. The morphology analysis of the surface before and after the ac-
tivation procedure revealed differences in silver distribution indicating segregation/diffusion of the metallic ele-
ment to the ﬁlm's surface.
Thus, the results indicate that the silver activation step is responsible for an antimicrobial effect of the coatings,
due to silver oxidation and silver ion release.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
With the increase of the elderly population and health problems,
that are arising nowadays, the number of hip joint prosthesis used
worldwide is rapidly growing, and is unfortunately associated with a
rising number of implant-associated infections [1,2]. Bacterial adhesion
on implants is the initial cause of infection [3], and can be translated to
the serious risk of implants' failure, with all negative consequences for
the patient, health services and the high costs associated [4]. Even
with all surgical procedures, like medical devices sterilization and skin
preparation [5], bacterial infection at the site of implanted medicalinho, Campus of Azurém, 4800-devices, such as catheters and artiﬁcial prosthetics, presents a serious
problem in the biomedical ﬁeld [2,6–8].
Implant infections in orthopedics, as well as in many other medical
ﬁelds, aremainly caused by staphylococci [9]. Staphylococcus epidermidis
(S. epidermidis) has emerged as one of the major nosocomial pathogens
associated with these infections. This bacterium is an opportunistic mi-
croorganism and has the ability to resist to antibiotic therapy and host
defenses [10], which may explain the signiﬁcant number of implant-
associated infections. The initial adhesion of these microorganisms to
biomaterials' surface is thought to be an important stage in their coloni-
zation [11]. The infectious pathogens aremotionless, ormetabolically in-
active, during the ﬁrst six hours after surgery, period known to be critical
for preventing infection [12]. Thereafter, bacterial bioﬁlm – deﬁned as a
structured community of bacterial cells enclosed in a self-produced polymer-
ic matrix and that are adherent to an inert or living surface [4] – is often
associated with these types of infections. Once the bacterial community
is in the bioﬁlm stage antibiotic treatments do not reveal efﬁcacy, and
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ous problem for public health [13]. For these reasons, it is better to pre-
vent the earlier stages of bacteria adhesion, instead of trying to
eliminate the problem at a later phase where microorganisms are in a
more complex stage, which demands new approaches in the orthopedic
ﬁeld, in order to reduce patientmorbidity andmortality associated to hip
surgery infection [14], and consequently reduce health costs [6].
One of the strategies is themodiﬁcation of implant surfaces [7,15,16]
with the aim of eliminating the infection of biomedical implants [6,17],
and also improving their chemical, mechanical, and tribological charac-
teristics, important features in biomedical devices. The use of nanocom-
posite protective ﬁlms, based on the combination of various transition
metal carbides, nitrides and carbonitrides, has already been reported
[18–23]. Within these materials, zirconium carbonitride (ZrCN) starts
to appear as a promising material for biomedical use [24–26].
Silver has a historic performance inmedicine due to its powerful an-
timicrobial activity [27–34], with a broad-spectrum of activity against
different microorganisms which usually implies the oxidation of metal-
lic silver to Ag+ [35,36]. Since bacterial infections are associated with
prosthetic failures, silver has been considered as a coating of invasive
medical devices [37], not only due to its reported antimicrobial effect
but also because due to of the absence of toxicity of the active Ag+ to
human cells [36].
Although the mechanism of silver antimicrobial activity is not fully
understood, it is suggested that silver ions act by strongly binding to
critical biologicalmolecules (proteins, DNA, RNA), disrupting their func-
tions [30,35], as well as by generating reactive oxygen species (ROS),
which are toxic to bacterial cells, obtaining a synergic bactericidal effect
between ionic silver and ROS [38]. However, in a recent study published
by Carvalho et al. [39], using Ag–TiCN system, silver ionization seems to
be insufﬁcient or even non-existent and the samples did not showed an-
timicrobial activity. So, in order to promote antimicrobial activity, on
this type of coatings, it is essential that the silver ionization occurs,
preventing microbial adhesion and subsequent bioﬁlm formation.
Therefore, the proposed challenge for this type of materials is to ensure
the ionization of silver, sincemetallic silver present in the coatings is not
an active chemical element and has a very low rate of dissolution in bi-
ological media [40].
This work reports the deposition of metallic silver (11 atomic per
cent (at.%)) embedded in a zirconium carbonitride (ZrCN) matrix onto
stainless steel 316 L substrates, by DC reactive magnetron sputtering.
This multiphase structure may have effect on the biological properties
of the coatings [41], also reported by other studies [42]. Thereafter, coat-
ings were subjected to a treatment with 5% (w/v) sodium hypochlorite
(NaClO), designed as silver activation, in order to increase the rate of sil-
ver oxidation. NaClO is known as a sterilizing agent in many different
ﬁelds, such aswater puriﬁcation,metal disinfection and the sterilization
of wounds [43].
In this paper the silver activation process to enhance the antibacteri-
al properties of Ag–ZrCN coatings is reported. The morphological and
chemical changes before and after the activation procedure were mon-
itored to assess the antimicrobial activity of the developed surfaces.
2. Materials and methods
2.1. Coatings production
The coatings were deposited onto 316 L stainless steel substrates by
unbalancedmagnetron sputtering in a closed ﬁeld conﬁguration known
as Physical Vapor Deposition (PVD) process. Prior to each deposit, a
cleaning pre-treatment was performed, on the substrates, to remove
all impurities and traces of grease, by ultrasonic baths using distilled
water after ethanol and then acetone during 10 min for each solution.
The two targets (one of pure zirconium and another composed by
zirconium and silver pellets) and substrates were further cleaned by
an in-situ argon plasma etching process, during 20 min, to eliminateremaining impurities on the surfaces. After the cleaning process, a zirco-
nium interlayer was deposited, in order to ensure good adhesion be-
tween the stainless steel and Ag–ZrCN multifunctional coating. Finally,
the coatingswere produced using a pure Zr target and amodiﬁed Zr tar-
get with silver pellets placed on the erosion area (Zr–Ag target). The
current density of 10 mA cm−2 was kept constant for the Zr target,
but the current density of the Zr–Ag target was changed between 0
and 2.5 mA cm−2. With these conditions, two samples were produced,
one without silver, named Ag 0, and another with 11 at.% of silver,
namedAg 11. To obtain homogenousmultifunctional Ag–ZrCNcoatings,
samples were placed on a rotational substrate holder at a constant
speed of 8 rpm. The sputtering atmosphere was kept in a constant
ﬂow of argon (60 standard cubic centimeters per minute (sccm)), acet-
ylene (1.2 sccm) and nitrogen (4 sccm). The deposition temperature
(373 K), polarization potential on the substrate holder (bias) (−50 V),
and work pressure (2.1 × 10−1 Pa) were monitored and kept constant
during the deposition.2.2. Silver activation
All samples used in this study were sterilized by autoclave, for
15 min, at 121 °C. In order to improve the oxidation of silver, an activa-
tion procedure was performed by immersing the samples in a 5% (w/v)
commercial sodium hypochlorite (NaClO) solution (Limpolar, Portugal)
for 5min. After three consecutive washes in deionizedwater, to remove
the remaining oxidizing solution, samples were dried on air (inside a
ﬂow chamber) and tested. The activation procedurewas also performed
on zirconium carbonitride coatings without silver (Ag 0), to control the
process and verify possible degradation of the coating when immersed
in the oxidant.
The morphology of each coating (before and after activation) was
evaluated by Scanning Electron Microscopy (NanoSEM 200-EDAX-
Nova) in both backscattering (BSE) and secondary electron (SE) modes.2.3. Chemical and physical analysis
The chemical composition of the coatings, as-deposited, was deter-
mined by electron probe microanalysis technique (EPMA) using a
Cameca equipment, model Camebax SX50. Five measurements were
performed for each sample on randomly selected zones of the surface.
The accelerating voltage of the electron beamwas 10 kV and the current
40 nA.
The evolution of the compositional proﬁle of the coatings before and
after activation was evaluated by Glow Discharge Optical Emission
Spectroscopy (GDOES). GDOES experiments were performed to assess
the compositional proﬁle of the sterilized as deposited Ag–ZrCN coat-
ings (Ag 11), Ag 11 coatings after the activation process (Ag 11_act)
and Ag 11_act coatings after the microbiological halo test (Ag 11_act
after Halo). GDOES experiments were also performed on ZrCN coatings,
before (Ag 0) and after activation (Ag 0_act). The tests were performed
using a Jobin YvonRFGDProﬁler equippedwith a 4mmdiameter anode
and operating at a typical radio frequency discharge pressure of 650 Pa
and a power of 40 W.
X-ray photoelectron spectroscopy (XPS) was used for the character-
ization of the oxidation states of the chemical elements of the coating
before and after the activation step as well as after the microbiological
tests. XPS spectra were acquired in an ultrahigh vacuum system at a
base pressure below 8 × 10−8 Pa using a hemispherical analyzer
(SPECS EA-10 Plus). The pass energy was 15 eV giving a constant reso-
lution of 0.9 eV. The Ag 3d5/2 line at 367.9 eV was used in order to cal-
ibrate the binding energies. A twin anode (Mg and Al) x-ray source was
operated at a constant power of 300WusingMgKα radiation. The sam-
ples were not sputter-cleaned. Deconvolution software CasaXPS was
used for spectra analysis of the samples.
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The antibacterial activity of Ag–ZrCN coatings was examined using
the zone of inhibition (ZOI) test [29], using the size of the growth inhi-
bition halo as a qualitative measure of the activity of the sample.
In preparation for the ZOI study assays, a single colony of
S. epidermidis (S. epidermidis, IE186 strain, a clinical isolate belonging
to the CEB Bioﬁlm Group collection) was inoculated on Tryptic Soy
Broth (TSB,Merck) and incubated for 18 h at 37 °C, and 120 rpm. There-
after, the resultant cell suspension was adjusted to an optical density
(OD) of 1.0 at 640 nm,measured on ELISA (enzyme-linked immunosor-
bent assay) absorbance reader (Sunrise™, Tecan, Austria) and properly
diluted to obtain 1 × 107 CFU·mL−1.
1 mL of the cellular suspension was added to 14 mL of cooled TSB
agar (TSA, Merck) and after placed into sterile plastic Petri dishes.
After agar medium solidiﬁcation, the sterilized Ag–ZrCN samples
(before and after activation) were placed on the center of the Petri
dishes and cultured for 24 h, at 37 °C. Following the incubation period,
the zone of transparent medium formed around the sample was mea-
sured, indicative of bacteria growth absence. All experiments were run
in triplicate per sample (technical replicates), on three independent oc-
casions (biological replicates).
3. Results and discussion
In this work, coatings deposited by reactive magnetron sputtering
were submitted to an activation procedure in order to evaluate its effect
on the enhancement of silver ionization. The modiﬁed surfaces were
characterized by several techniques and their antimicrobial activity
estimated.
3.1. Chemical and physical analysis
Table 1 shows the chemical composition of the samples as-
deposited, measured by EPMA. Further details concerning the chemical
composition versus deposition parameters, of the similar samples, can
be found elsewhere [44,45].
The ﬁlms' morphologywas evaluated before and after the activation
process, to verify the existence of morphological alterations and/or ﬁlm
delamination due to the oxidizing agent activity. Fig. 1a) shows the Ag 0
coatings before activation, revealing pronounced boundariesmimicking
the substrate grains and a characteristic columnar structure (inset in
Fig. 1a)). After the activation process (Fig. 1b)), the coatings morpholo-
gy did not change signiﬁcantly and no evidence of ﬁlm delamination
was observed. In fact, other researchers have reported that ZrCN coat-
ings are resistant to hydrogen peroxide (H2O2), an oxidizing agent
used in hospital environment [24].
Ag 11 coatings exhibit an overall morphology similar to coatings be-
fore silver activation, Ag 0 (Fig. 2a)), but with silver nanoparticles dis-
tributed on the surface. After the activation procedure (Fig. 2b)),
signiﬁcant morphological changes were noted, showing the formation
of silver-based nanoparticles dispersed over the entire ﬁlm surface.
These results suggest that the NaClO solution penetrates the coating,Table 1
Chemical composition of the deposited coatings, measured by EPMA (with standard devi-
ation between 0.2 and 0.8) and current density applied to each target, during the
deposition.
Samples Coating composition (at. %) JZr
(mA/cm2)
JZr + Ag
(mA/cm2)
Zr N C O Ag
Ag 0 36 19 37 8 0 10 0
Ag 11 32 29 19 9 11 7.5 2.5thus activating not only the superﬁcial silver but also some silver
present within the coating, leading to changes in surface morphology.
Nevertheless, it is also important to understand the distribution of silver
along the coating thickness and how deep the oxidizing agent evolve
within the coatings, in order to promote silver ionization and its subse-
quent migration to the coating surface. Hence, for further investigation
of Ag diffusion through the coating and evolution in terms of distribu-
tion, a GDOES technique was performed.
Figs. 3 and 4 show the GDOES depth proﬁle composition of the sam-
ple Ag 11 before and after activation, respectively, revealing very differ-
ent silver distribution proﬁles mainly on the surface of the ﬁlm,
conﬁrming the observations made by SEM (Fig. 2). In fact, a signiﬁcant
increase in the silver concentration is visible for the ﬁrst 7 nm in the
activated samples (Fig. 4), that should be promoted from silver
segregation/diffusion from the inside to the ﬁlm surface. This behavior
was not observed before activation, being reported for similarmaterials
only after thermal annealing [46]. The other chemical elemental com-
position did not vary signiﬁcantly, conﬁrming the stability of the ZrCN
phase after the activation process.
The results presented in Fig. 4 corroborate the fact that silver activa-
tion process can induce the oxidation of silver promoting the diffusion
of the metallic ion through the coating, increasing the concentration of
silver on the surface, without compromising the overall chemical com-
position integrity. This diffusion/segregation and the chemical reaction
between silver and the oxidant agent, is achieved during few minutes
of the activation process, which contributes to the protection of the
coating of possible oxidative attacks. Despite the surface changes, it is
important to highlight the fact that only the ﬁrst 7 nmof theﬁlm surface
is modiﬁedwhichmay also be related to the short time of the activation
step and to the dense morphology presented by the Ag 11 coating
(Fig. 2a)).
3.2. XPS analysis
SEM and GDOES results indicate that the major changes occurred at
the surface of the coatings and therefore XPS technique was used to
characterize the oxidation state of the major chemical elements. It is
worth noting that coatings were not sputtered before analysis, leading
to the presence of all environmental contaminants, thereby ensuring
that key elements present on the surface of the samples would not be
disposed of as contaminants.
The binding energy results are shown in Fig. 5. For the Ag 11 and Ag
11_act surfaces, the C–C bond, at 285.0 eV [47], indicate the presence of
an amorphous carbon phase, characteristic of these ﬁlms [22,44,45,48].
The C 1 s high resolution spectra also shows peaks at ~286.4 and
~288.1 eV, attributed either to C–NandC–Obonds,which could indicate
both CNx amorphous phases [49]. This fact correlates with the compo-
nent observed at ~399 eV in the N 1 s, for Ag 11.
The results of Ag 11 as-deposited show the Zr–O bond (182.3 eV)
[22], revealing the high reactivity of this element with the environment
and its ability to form passive layers, that could beneﬁt the corrosion re-
sistance [48], important features for biomedical devices. After the acti-
vation procedure, it is believed that this passive ZrO2 layer remains on
the material surface, in its hydrated form, which explains the decrease
of its binding energy [50]. However, themain focus is on the silver spec-
trum for the different surfaces: Ag 11 and Ag 11_act. For Ag 11 the silver
spectra revealed a broad band at 369.4 eV, in addition to the metallic
peak at 368.4 eV. The former band is attributed to metallic sub-
nanoparticles associated with clusters smaller than 4 nm [51]. This
band has also been observed by Calderon et al. [44] in ZrCN–Ag samples.
After the activation procedure, the peaks related to Ag-clusters andme-
tallic silver disappear and a new peak arises, shifted to lower energies,
which can be attributed to silver oxides, since oxidation leads to shifting
of binding energy to lower values accompanied by a peak broadening,
which clearly discloses the oxidation of silver to Ag+ state [52]. In fact,
the silver oxide peak was identiﬁed at 367.8 eV, conﬁrming the surface
Fig. 1. SEM micrographs of the surface of the Ag 0 thin ﬁlm: a) before and b) after activation with NaClO. The inset in a) presents the Ag 0 samples cross-section view.
Scheme 1.
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intrinsic characteristics, clusters in coatings are more easily ionized.
When the coatings are immersed in the sodium hypochlorite, the solu-
tion penetrates into the coating, oxidizes the silver,with subsequent dif-
fusion of ions to the surface, where returns to the oxide compound once
the surface is removed from the solution. This explains the emergence
of this new peak and the absence of the clusters and metallic peaks.
These ﬁndings are in agreement with the peak observed at 529.7 eV,
in the O 1 s high resolution spectra, with evident changes before and
after activation.
There is no evidence of chloride in the samples after the activation
procedure, which can be considered contradictory to the well-known
afﬁnity of silver to chlorinated solutions [53], inducing the formation
of AgCl. Thus, more insights are needed, in the reaction mechanism on
silver activation, in order to understand the chemical reaction between
silver in the coatings and the oxidant agent.3.3. Mechanism on silver activation
It is well known that the antimicrobial activity of silver is dependent
of the presence of silver ions. The Ag+ easily binds to electron donor
groups from biological molecules containing sulfur (S), oxygen (O) or
nitrogen (N), also leading to the formation of reactive oxygen species
(ROS), which are toxic to bacterial cells [54]. Thus, for an effectiveFig. 2. SEMmicrograph of the surface of the Ag 11 thin ﬁlm: a) before and b) after activation wi
show the SEM image from the sample surface where Ag agglomerates (BSE image) is evident.antimicrobial effect, the formation and release of ionic silver to the path-
ogenic medium is required [36].
To promote the active and powerful silver ionization, an activation
procedure was performed using an oxidizing compound, as described
in Section 2.
The reaction between metallic silver (presented in the Ag 11 coat-
ings) and the sodiumhypochlorite, named silver activation, is presented
in Scheme 1.
Scheme 1. Chemical reaction between silver and sodium hypochloriteDue to the large afﬁnity between silver and chloride solutions [53],
together with the enthalpy of formation of AgCl (ΔfHo298 =
−127.01 KJ mol−1), which is more negative than Ag2O (ΔfHo298 =
−31.1 KJmol−1) [55], it was expected that this reaction produces ama-
jority of silver chloride (AgCl). However, we hypothesized that when in
contact with the aqueous hypochlorite solution, an alkaline and strong
oxidant medium, silver in the Ag–ZrCN coatings may ﬁrstly form
AgOH on its surface. While AgOH is not stable at room temperature,
his enthalpy of formation (ΔfHo298 =−125.7 KJ mol−1) is very similar
to AgCl (ΔfHo298 = −127.01 KJ mol−1), serving as a measure of theth NaClO. The inset in a) presents the Ag 11 samples cross-section view and the inset in b)
Fig. 3. GDOES proﬁle of Ag 11 thin ﬁlm, before activation with NaClO. The inset in the ﬁgure shows the proﬁle in the ﬁrst 20 nm of the coating.
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of hydroxyl ions, whose presence has been proved on silver electrode
surface [57]. Hence, during the activation procedure, a competitiveFig. 4. GDOES proﬁle of Ag 11 thin ﬁlm after activation with NaClO. The iadsorption of OH− and Cl− on silver surface may explain the preferen-
tial formation of silver hydroxide instead of silver chloride. Subsequent-
ly, silver hydroxide will induce the formation of Ag+ according tonset in the ﬁgure shows the proﬁle in the ﬁrst 20 nm of the coating.
Fig. 5. XPS spectra of Ag 3d, O1s, Zr 3d C1s and N1s core levels of the Ag 11 and Ag 11_act coatings.
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Ag–O is identiﬁed in the coating surface after the activation procedure
and no evidences of the Ag–Cl bond were detected.
Scheme 2. Silver oxide formation from silver hydroxideScheme 2.Scheme 3. Formation of Ag+ from silver oxideFig. 6.Growth inhibition halo tests: a) Ag 11 coating with no halo, b) Ag 11_act coating, after sil
c) Ag 0 after activation with no antimicrobial activity.
Scheme 3.In fact, the formation of oxidized nano silver was the focal point in
this procedure, which can inhibit bacterial growth [53], since its bio-
availability allows increasing biocidal Ag+ formation and mobility, pro-
viding a constant concentration of Ag+ ions in aqueous environments
[40].
In order to demonstrate the release of Ag+ into the biological medi-
um and subsequently the antimicrobial activity of these activated silver
coatings, antimicrobial tests were performed.
3.4. Antimicrobial properties
Fig. 6 shows the growth inhibition halo tests performed using Ag 11
coatings, before (a) and after (b) silver activation, aswell as Ag 0 coating
after activation (c). The pathogenic bacteria and medium selected forver activation, with red circle highlighting the formation of the growth inhibition halo, and
Fig. 7. SEM micrograph of the surface of the activated Ag 11 thin ﬁlm after the microbio-
logical test.
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onization [40].
From Fig. 6, it is clear that the growth inhibition halo (clear biological
medium, with no bacteria growth) formed around the sample after acti-
vation (Fig. 6b)), an indicator of antimicrobial activity. These results can
be explained considering the chemical reaction which takes place during
the activation procedure. During the activation process, silver oxide was
formed on surface, as previously discussed. Ag+ was formed (Scheme
3)when in close contact with amoist and electrolytemedium, and spon-
taneously diffuses to the surrounding medium (bacteria suspension and
agar), killing or inhibiting bacteria growth [15]. Antimicrobial activity in
Ag 11 activated coating was noticed during the 24 h of the halo test. Ac-
cording to Poelstra and Barekzi [12], theﬁrst 6 h after surgery is crucial forFig. 8. GDOES silver proﬁle of different coatings: Ag 11 (as-deposited), Ag 11_act (activated) an
resents the silver XPS proﬁle in the Ag 11_act and Ag 11_act after halo test (coatings before anpreventing infection, since the infectious pathogens are still latent or
metabolically inactive. During the ﬁrst 24 h of colonization and contact
between bacteria and the indwelling medical devices, bioﬁlm develops
and becomes mature [3], indicating that microorganisms are irreversibly
attach and enclosed in amatrix of exopolymeric products [4], resisting to
the host immune system and antibiotic treatment.
In the entire process, Ag 0 coatings were used as control before and
after immersion onNaClO, to eliminate the possibility that the oxidizing
agent residues could be responsible for bacteria death. No growth inhi-
bition zone was observed for both Ag 0 and Ag 0_act, excluding the ac-
tion of the remaining oxidizing agent. Also no bacterial inhibition
growth was seen on sterilized as-deposited Ag 11 coating (Fig. 6a)).
SEM, GDOES assay andXPS spectroscopywere also performed on ac-
tivated coating, Ag 11, after contact with the microbiological test
(Ag 11_act after halo). Remarkably, SEM analysis reveals that there are
no visible silver-based nanoparticles on the coating surface (Fig. 7), in
agreement with the composition analysis made by GDOES and XPS, as
shown in Figs. 4 and 5. The silver of the surface layer of Ag 11_act disap-
peared after contact with the biological medium of the microbiological
test (Ag 11_act after halo), which indicates that during the incubation
period silver ionizes and subsequently diffuses through the culture me-
dium, suppressing the functions of microbial cells, leading to their
death. This fact is further conﬁrmed by XPS results, where is possible
to observe the decrease of silver concentration (Fig. 8 inset).
Due to the stability of the ZrCNmatrix it is desirable that silver is lo-
cated close to the surface, since bacterial adhesion and proliferation take
place on the surface of thematerial [6]. Previously to the activation step,
as mentioned, silver nanoparticles were embedded in the ZrCN coating,
visible but less available to ionize and react with the surrounding envi-
ronment. After the activation procedure, signiﬁcant changes in shape,
size, distribution density of the silver particles and cover ratio have
been achieved, as discussed on basis of SEM micrographs (Fig. 2),
GDOES proﬁle (Fig. 4) and XPS spectra (Fig. 5). The silver based nano-
particles have diffused to the surface of Ag 11 coating, increasing its
availability to ionize and diffuse through the biological medium during
the growth inhibition halo test. These nanoparticles are in fact strongly
attached to the matrix since they are not removed by mechanical ma-
nipulation of the samples and successive washings performed befored Ag 11_act after halo (after growth inhibition halo test), in the ﬁrst 20 nm. The inset rep-
d after halo test).
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antimicrobial activity is not yet fully investigated and understood. How-
ever, it is clear that after exposure to the culture medium, silver ion re-
lease occurs in the activated Ag 11 coating, granting the antimicrobial
activity observed (Fig. 6).
The results show the abrupt decrease of silver content on the out-
most layer after themicrobiological tests in agreementwith SEM obser-
vation (Fig. 7), probably due to silver diffusion into the culturemedium,
in contrast with the proﬁle of the activated coating, where a high silver
concentration can be observed in the ﬁrst 7 nm (Fig. 4).4. Conclusion
In order to increment the silver ionization in samples with approxi-
mately 11% of Ag, sample Ag 11, a silver activation procedure, with 5%
(w/v)NaClO solution,was successfully performed. Thismethod induced
signiﬁcant changes in shape, size and distribution density of the silver
particles, as well as an increase of the cover ratio. XPS results disclosed
thepresence of silver oxides on the coatings surface, afterNaClO immer-
sion. This activated Ag 11 coating showed an antimicrobial effect, ac-
cording to the growing inhibition halo test, suggesting that silver ions
diffuse through the media.
SEM images obtained after the microbiological tests revealed an
enormous decrease in silver content, showing the silver top layer
disappearance.
The results demonstrate that the developed Ag–ZrCN coatings, after
the activation process, have potential to reduce bacteria adhesion and
consequently bioﬁlm formation on medical devices.Acknowledgments
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